Showing 1 - 10 of 129
Persistent link: https://www.econbiz.de/10012182278
Persistent link: https://www.econbiz.de/10011635704
Persistent link: https://www.econbiz.de/10012115822
Persistent link: https://www.econbiz.de/10008701491
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales Perspective™ 2004Q4 - 2016Q3 data. We define a unique product market ("molform"), consisting of the combination of a molecule active ingredient and a route of administration...
Persistent link: https://www.econbiz.de/10012480138
We establish four facts concerning competition among U.S. generic drug suppliers, using IQVIA's National Sales PerspectiveTM 2004Q4 – 2016Q3 data. We define a unique product market (“molform”), consisting of the combination of a molecule active ingredient and a route of administration...
Persistent link: https://www.econbiz.de/10012862864
Persistent link: https://www.econbiz.de/10001832900
branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …
Persistent link: https://www.econbiz.de/10013139118
We examine the role of consumption externalities in the demand for pharmaceuticals at both the brand level and over a … brand valuation; equations relating equilibrium market shares to quality-adjusted prices and marketing levels; and diffusion …
Persistent link: https://www.econbiz.de/10012470978
We examine the role of network effects in the demand for pharmaceuticals at both the brand level and for a therapeutic …
Persistent link: https://www.econbiz.de/10012471776